BIOMAT Database Logo BIOMAT Database Logo

[Antithrombin III (AT III)]. 1995

K Okajima
Department of Laboratory Medicine, Kumamoto University Medical School.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

K Okajima
Safety of virus inactivated antithrombin III concentrate antithrombin III immuno (AT III).
March 1992, Thrombosis research,
K Okajima
Hereditary dysfunctional antithrombin III (AT-III Vicenza)
February 1981, Thrombosis and haemostasis,
K Okajima
A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.
September 1985, Thrombosis research,
K Okajima
Homozygous variant of antithrombin III: AT III Fontainebleau.
August 1986, Thrombosis and haemostasis,
K Okajima
Antithrombin-III (AT-III) deficiency spanning four generations.
December 1991, Thrombosis and haemostasis,
K Okajima
[Antithrombin III. Antithrombin].
April 1982, Orvosi hetilap,
K Okajima
Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, "antithrombin III Toyama".
July 1987, Thrombosis research,
K Okajima
An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
August 1987, British journal of haematology,
K Okajima
Antithrombin III Alger: a new homozygous AT III variant.
April 1986, Thrombosis and haemostasis,
K Okajima
Proceedings: Defibrinogenation procedures for antithrombin III (AT-III) biological assay.
September 1975, Thrombosis et diathesis haemorrhagica,
Copied contents to your clipboard!